1-3 of 3
Fernando Carvajal-Borda, DVM
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Characterization of Prgn-3006 Ultracar-T™ for the Treatment of AML and MDS: Non-Viral, Multigenic Autologous CAR-T Cells Administered One Day after Gene Transfer

Tim Chan, PhD, Xiaohong Ma, Fernando Carvajal-Borda, DVM, Jose Velez, Jacques Plummer, Lindsey Shepard, Rutul R Shah, David A Sallman, MD, Helen Sabzevari, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2660.
https://doi.org/10.1182/blood-2019-130617
Published: 2019
Journal Articles

CD19-Specific Chimeric Antigen Receptor-Modified T Cells with Safety Switch Produced Under "Point-of-Care" Using the Sleeping Beauty System for the Very Rapid Manufacture and Treatment of B-Cell Malignancies

Tim Chan, PhD, John Gallagher, Nai-Lin Cheng, PhD, Fernando Carvajal-Borda, DVM, Jacques Plummer, Adeline Govekung, John A Barrett, PhD, Pranay D. Khare, PhD, Laurence J N Cooper, MDPhD, Rutul R Shah
Journal: Blood
Blood (2017) 130 (Supplement 1): 1324.
https://doi.org/10.1182/blood.V130.Suppl_1.1324.1324
Published: 2017
Journal Articles

Autologous T Cells Modified to Co-Express CD33-Specific Chimeric Antigen Receptor and a Kill Switch for Treatment of CD33 + Acute Myeloid Leukemia

Degang Song, PhD, Michael H Swartz, Linhua Tian, Fernando Carvajal-Borda, DVM, Jacques Plummer, Rutul R Shah, William G Wierda, MD PhD, Laurence J N Cooper, MDPhD, Tim Chan, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1376.
https://doi.org/10.1182/blood.V130.Suppl_1.1376.1376
Published: 2017